Telegraph Hill Partners

Telegraph Hill Partners (THP) is a prominent San Francisco-based venture capital firm established in 2001, specializing in growth equity investments within the life sciences, medical device, and healthcare information technology sectors. The firm primarily targets commercial-stage companies, seeking to partner with businesses that have demonstrated market traction and are poised for significant expansion. THP's investment philosophy emphasizes providing not just capital, but also strategic guidance and operational support to its portfolio companies, leveraging the deep industry expertise of its partners.

THP's investment strategy is focused on providing substantial capital to support the growth trajectories of its chosen enterprises. The firm typically deploys initial checks ranging from $10 million to $50 million, indicating a preference for later-stage, more mature companies within its specialized domains. This focused approach allows THP to engage deeply with its portfolio, helping them navigate complex market dynamics, scale operations, and accelerate product development or market penetration. Their commitment extends beyond initial funding, often participating in follow-on rounds as companies mature.

Over its two decades of operation, Telegraph Hill Partners has demonstrated a consistent ability to raise substantial capital, underscoring investor confidence in its specialized strategy. The firm has successfully closed multiple funds, with its most recent, Telegraph Hill Partners VI, raising $600 million in 2022. Cumulatively, THP has raised approximately $1.95 billion across its six funds since its inception. This substantial capital base has enabled the firm to build a diverse portfolio of over 100 investments, contributing to significant advancements and innovations across the healthcare landscape. Their track record includes more than 30 successful exits, reflecting their proficiency in identifying and nurturing high-potential companies.